List of Tables
Table 1. Global Neurointerventional Therapy Pathway Products Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Neurointerventional Therapy Pathway Products Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Neurointerventional Therapy Pathway Products Market Competitive Situation by Manufacturers in 2024
Table 4. Global Neurointerventional Therapy Pathway Products Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Neurointerventional Therapy Pathway Products Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Neurointerventional Therapy Pathway Products Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Neurointerventional Therapy Pathway Products Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Neurointerventional Therapy Pathway Products Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Neurointerventional Therapy Pathway Products, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Neurointerventional Therapy Pathway Products, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Neurointerventional Therapy Pathway Products, Product Type & Application
Table 12. Global Key Manufacturers of Neurointerventional Therapy Pathway Products, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Neurointerventional Therapy Pathway Products by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurointerventional Therapy Pathway Products as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Neurointerventional Therapy Pathway Products Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Neurointerventional Therapy Pathway Products Sales by Region (2020-2025) & (K Units)
Table 18. Global Neurointerventional Therapy Pathway Products Sales Market Share by Region (2020-2025)
Table 19. Global Neurointerventional Therapy Pathway Products Sales by Region (2026-2031) & (K Units)
Table 20. Global Neurointerventional Therapy Pathway Products Sales Market Share by Region (2026-2031)
Table 21. Global Neurointerventional Therapy Pathway Products Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Neurointerventional Therapy Pathway Products Revenue Market Share by Region (2020-2025)
Table 23. Global Neurointerventional Therapy Pathway Products Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Neurointerventional Therapy Pathway Products Revenue Market Share by Region (2026-2031)
Table 25. North America Neurointerventional Therapy Pathway Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Neurointerventional Therapy Pathway Products Sales by Country (2020-2025) & (K Units)
Table 27. North America Neurointerventional Therapy Pathway Products Sales by Country (2026-2031) & (K Units)
Table 28. North America Neurointerventional Therapy Pathway Products Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Neurointerventional Therapy Pathway Products Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Neurointerventional Therapy Pathway Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Neurointerventional Therapy Pathway Products Sales by Country (2020-2025) & (K Units)
Table 32. Europe Neurointerventional Therapy Pathway Products Sales by Country (2026-2031) & (K Units)
Table 33. Europe Neurointerventional Therapy Pathway Products Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Neurointerventional Therapy Pathway Products Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Neurointerventional Therapy Pathway Products Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Neurointerventional Therapy Pathway Products Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Neurointerventional Therapy Pathway Products Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Neurointerventional Therapy Pathway Products Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Neurointerventional Therapy Pathway Products Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Neurointerventional Therapy Pathway Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Neurointerventional Therapy Pathway Products Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Neurointerventional Therapy Pathway Products Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Neurointerventional Therapy Pathway Products Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Neurointerventional Therapy Pathway Products Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Neurointerventional Therapy Pathway Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Neurointerventional Therapy Pathway Products Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Neurointerventional Therapy Pathway Products Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Neurointerventional Therapy Pathway Products Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Neurointerventional Therapy Pathway Products Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Neurointerventional Therapy Pathway Products Sales (K Units) by Type (2020-2025)
Table 51. Global Neurointerventional Therapy Pathway Products Sales (K Units) by Type (2026-2031)
Table 52. Global Neurointerventional Therapy Pathway Products Sales Market Share by Type (2020-2025)
Table 53. Global Neurointerventional Therapy Pathway Products Sales Market Share by Type (2026-2031)
Table 54. Global Neurointerventional Therapy Pathway Products Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Neurointerventional Therapy Pathway Products Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Neurointerventional Therapy Pathway Products Revenue Market Share by Type (2020-2025)
Table 57. Global Neurointerventional Therapy Pathway Products Revenue Market Share by Type (2026-2031)
Table 58. Global Neurointerventional Therapy Pathway Products Price (US$/Unit) by Type (2020-2025)
Table 59. Global Neurointerventional Therapy Pathway Products Price (US$/Unit) by Type (2026-2031)
Table 60. Global Neurointerventional Therapy Pathway Products Sales (K Units) by Application (2020-2025)
Table 61. Global Neurointerventional Therapy Pathway Products Sales (K Units) by Application (2026-2031)
Table 62. Global Neurointerventional Therapy Pathway Products Sales Market Share by Application (2020-2025)
Table 63. Global Neurointerventional Therapy Pathway Products Sales Market Share by Application (2026-2031)
Table 64. Global Neurointerventional Therapy Pathway Products Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Neurointerventional Therapy Pathway Products Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Neurointerventional Therapy Pathway Products Revenue Market Share by Application (2020-2025)
Table 67. Global Neurointerventional Therapy Pathway Products Revenue Market Share by Application (2026-2031)
Table 68. Global Neurointerventional Therapy Pathway Products Price (US$/Unit) by Application (2020-2025)
Table 69. Global Neurointerventional Therapy Pathway Products Price (US$/Unit) by Application (2026-2031)
Table 70. Medtronic Company Information
Table 71. Medtronic Description and Business Overview
Table 72. Medtronic Neurointerventional Therapy Pathway Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Medtronic Neurointerventional Therapy Pathway Products Product
Table 74. Medtronic Recent Developments/Updates
Table 75. MicroVention TERUMO Company Information
Table 76. MicroVention TERUMO Description and Business Overview
Table 77. MicroVention TERUMO Neurointerventional Therapy Pathway Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. MicroVention TERUMO Neurointerventional Therapy Pathway Products Product
Table 79. MicroVention TERUMO Recent Developments/Updates
Table 80. Johnson & Johnson Company Information
Table 81. Johnson & Johnson Description and Business Overview
Table 82. Johnson & Johnson Neurointerventional Therapy Pathway Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Johnson & Johnson Neurointerventional Therapy Pathway Products Product
Table 84. Johnson & Johnson Recent Developments/Updates
Table 85. Penumbra Company Information
Table 86. Penumbra Description and Business Overview
Table 87. Penumbra Neurointerventional Therapy Pathway Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Penumbra Neurointerventional Therapy Pathway Products Product
Table 89. Penumbra Recent Developments/Updates
Table 90. Micro Therapeutics Company Information
Table 91. Micro Therapeutics Description and Business Overview
Table 92. Micro Therapeutics Neurointerventional Therapy Pathway Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Micro Therapeutics Neurointerventional Therapy Pathway Products Product
Table 94. Micro Therapeutics Recent Developments/Updates
Table 95. Medos International SARL Company Information
Table 96. Medos International SARL Description and Business Overview
Table 97. Medos International SARL Neurointerventional Therapy Pathway Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Medos International SARL Neurointerventional Therapy Pathway Products Product
Table 99. Medos International SARL Recent Developments/Updates
Table 100. APT Medical Company Information
Table 101. APT Medical Description and Business Overview
Table 102. APT Medical Neurointerventional Therapy Pathway Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. APT Medical Neurointerventional Therapy Pathway Products Product
Table 104. APT Medical Recent Developments/Updates
Table 105. Peijia Medical Company Information
Table 106. Peijia Medical Description and Business Overview
Table 107. Peijia Medical Neurointerventional Therapy Pathway Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Peijia Medical Neurointerventional Therapy Pathway Products Product
Table 109. Peijia Medical Recent Developments/Updates
Table 110. Aike Medical Equipment Company Information
Table 111. Aike Medical Equipment Description and Business Overview
Table 112. Aike Medical Equipment Neurointerventional Therapy Pathway Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Aike Medical Equipment Neurointerventional Therapy Pathway Products Product
Table 114. Aike Medical Equipment Recent Developments/Updates
Table 115. Shanghai HeartCare Medical Technology Company Information
Table 116. Shanghai HeartCare Medical Technology Description and Business Overview
Table 117. Shanghai HeartCare Medical Technology Neurointerventional Therapy Pathway Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Shanghai HeartCare Medical Technology Neurointerventional Therapy Pathway Products Product
Table 119. Shanghai HeartCare Medical Technology Recent Developments/Updates
Table 120. Shanghai Wallaby Medical Technologies Company Information
Table 121. Shanghai Wallaby Medical Technologies Description and Business Overview
Table 122. Shanghai Wallaby Medical Technologies Neurointerventional Therapy Pathway Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Shanghai Wallaby Medical Technologies Neurointerventional Therapy Pathway Products Product
Table 124. Shanghai Wallaby Medical Technologies Recent Developments/Updates
Table 125. Guangzhou Easycess Medical Company Information
Table 126. Guangzhou Easycess Medical Description and Business Overview
Table 127. Guangzhou Easycess Medical Neurointerventional Therapy Pathway Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Guangzhou Easycess Medical Neurointerventional Therapy Pathway Products Product
Table 129. Guangzhou Easycess Medical Recent Developments/Updates
Table 130. Zhuhai Ton-Bridge Medical Company Information
Table 131. Zhuhai Ton-Bridge Medical Description and Business Overview
Table 132. Zhuhai Ton-Bridge Medical Neurointerventional Therapy Pathway Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Zhuhai Ton-Bridge Medical Neurointerventional Therapy Pathway Products Product
Table 134. Zhuhai Ton-Bridge Medical Recent Developments/Updates
Table 135. Shanghai Lee Kai Technology Company Information
Table 136. Shanghai Lee Kai Technology Description and Business Overview
Table 137. Shanghai Lee Kai Technology Neurointerventional Therapy Pathway Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Shanghai Lee Kai Technology Neurointerventional Therapy Pathway Products Product
Table 139. Shanghai Lee Kai Technology Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Neurointerventional Therapy Pathway Products Distributors List
Table 143. Neurointerventional Therapy Pathway Products Customers List
Table 144. Neurointerventional Therapy Pathway Products Market Trends
Table 145. Neurointerventional Therapy Pathway Products Market Drivers
Table 146. Neurointerventional Therapy Pathway Products Market Challenges
Table 147. Neurointerventional Therapy Pathway Products Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Neurointerventional Therapy Pathway Products
Figure 2. Global Neurointerventional Therapy Pathway Products Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Neurointerventional Therapy Pathway Products Market Share by Type: 2024 & 2031
Figure 4. Microcatheter Product Picture
Figure 5. Distal Access Catheter Product Picture
Figure 6. Radial Artery Delivery Catheter Product Picture
Figure 7. Micro Guide Wire Product Picture
Figure 8. Others Product Picture
Figure 9. Global Neurointerventional Therapy Pathway Products Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Neurointerventional Therapy Pathway Products Market Share by Application: 2024 & 2031
Figure 11. Stroke
Figure 12. Coronary Heart Disease
Figure 13. Others
Figure 14. Global Neurointerventional Therapy Pathway Products Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Neurointerventional Therapy Pathway Products Market Size (2020-2031) & (US$ Million)
Figure 16. Global Neurointerventional Therapy Pathway Products Sales (2020-2031) & (K Units)
Figure 17. Global Neurointerventional Therapy Pathway Products Average Price (US$/Unit) & (2020-2031)
Figure 18. Neurointerventional Therapy Pathway Products Report Years Considered
Figure 19. Neurointerventional Therapy Pathway Products Sales Share by Manufacturers in 2024
Figure 20. Global Neurointerventional Therapy Pathway Products Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Neurointerventional Therapy Pathway Products Players: Market Share by Revenue in Neurointerventional Therapy Pathway Products in 2024
Figure 22. Neurointerventional Therapy Pathway Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Neurointerventional Therapy Pathway Products Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Neurointerventional Therapy Pathway Products Sales Market Share by Country (2020-2031)
Figure 25. North America Neurointerventional Therapy Pathway Products Revenue Market Share by Country (2020-2031)
Figure 26. United States Neurointerventional Therapy Pathway Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Neurointerventional Therapy Pathway Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Neurointerventional Therapy Pathway Products Sales Market Share by Country (2020-2031)
Figure 29. Europe Neurointerventional Therapy Pathway Products Revenue Market Share by Country (2020-2031)
Figure 30. Germany Neurointerventional Therapy Pathway Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Neurointerventional Therapy Pathway Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Neurointerventional Therapy Pathway Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Neurointerventional Therapy Pathway Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Neurointerventional Therapy Pathway Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Neurointerventional Therapy Pathway Products Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Neurointerventional Therapy Pathway Products Revenue Market Share by Region (2020-2031)
Figure 37. China Neurointerventional Therapy Pathway Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Neurointerventional Therapy Pathway Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Neurointerventional Therapy Pathway Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Neurointerventional Therapy Pathway Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Neurointerventional Therapy Pathway Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan Neurointerventional Therapy Pathway Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Southeast Asia Neurointerventional Therapy Pathway Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Neurointerventional Therapy Pathway Products Sales Market Share by Country (2020-2031)
Figure 45. Latin America Neurointerventional Therapy Pathway Products Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Neurointerventional Therapy Pathway Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Neurointerventional Therapy Pathway Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Neurointerventional Therapy Pathway Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Neurointerventional Therapy Pathway Products Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Neurointerventional Therapy Pathway Products Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Neurointerventional Therapy Pathway Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Neurointerventional Therapy Pathway Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Neurointerventional Therapy Pathway Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Neurointerventional Therapy Pathway Products by Type (2020-2031)
Figure 55. Global Revenue Market Share of Neurointerventional Therapy Pathway Products by Type (2020-2031)
Figure 56. Global Neurointerventional Therapy Pathway Products Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Neurointerventional Therapy Pathway Products by Application (2020-2031)
Figure 58. Global Revenue Market Share of Neurointerventional Therapy Pathway Products by Application (2020-2031)
Figure 59. Global Neurointerventional Therapy Pathway Products Price (US$/Unit) by Application (2020-2031)
Figure 60. Neurointerventional Therapy Pathway Products Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
